Gina M. Cavalier, a healthcare lawyer with extensive experience in regulatory counseling to medical device and pharmaceutical companies and healthcare providers and suppliers, has joined King & Spalding as a partner in its FDA and life sciences practice, in Washington, D.C., the firm announced today. Cavalier comes to King & Spalding from Reed Smith.

The Firm represented underwriters, led by Deutsche Bank, Credit Suisse and HSBC, in connection with a public offering by América Móvil, S.A.B. de C.V. of the equivalent of approximately U.S.$2.2 billion principal amount of debt securities denominated in euro and pounds sterling.  The debt securities consisted of €1 billion of 4.125% Senior Notes due 2019 and £500 million of 5.000% Senior Notes due 2026.

DLA Piper has advised Nuplex Industries Ltd. on the acquisition of the coating resins division of Bayer MaterialScience AG. The transaction includes the purchase of all shares in Viverso GmbH in Bitterfeld together with all assets belonging to this business in various regions throughout the world. The purchase price is €75 million. Located in Bitterfeld, Germany, the production plant for coating resin products went into operation in 1995 and is one of the most modern in the world. Since 2008, Bayer MaterialScience has had its coating resins business combined in Viverso GmbH.